<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>36</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>1998</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">RESULTS OF ALLOGENIC BONE MARROW TRANSPLANTATION IN CML IN IRAN</title>
    <FirstPage>55</FirstPage>
    <LastPage>58</LastPage>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName>A. khodabeh.</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>P.Nasseri.</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>M Jahani.</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>A.Ghavamzadeh.</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>I. Baybordi.</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>M. Mohyeddin.  G. Ghahremani</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Nineteen patterns with CML have been transplanted in our Bone Marrow Transplantation (BMT) section since 1991, The mean age of these patients was 26.05 (SD = 9.35). Our conditioning regimen for these patients was cyclophosphamide 60mglkg for 2 days and busulfan 4mglkg for 4 consecutive days. Eleven patients are still alive arid eight patients died during follow-up ranging from 6 months to 5 years. This review revealed a poor outcome for patients older than 30. There was also a rise in the mortality rate when the interval between diagnosis and BMT was longer than 2 years. In contrast with some previous reports, we found no relationship between spleen size in the pre-transplant period and BMT outcome, however recurrence of CM L after BMT correlates strongly with spleen size (P 1000/ml, PMN &gt; 5001ml. PLT &gt; 1000001ml) correlates directly with spleen size as well (P</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/1742</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/1742/1735</pdf_url>
  </Article>
</Articles>
